Capecitabine (X) single-agent therapy in patients (pts) with locally advanced/metastatic cholangiocarcinoma

被引：0
|
作者：
Sew, O. Sea [1 ]
Sookprasert, A. [1 ]
Bhudhisawad, V. [1 ]
Kaewket, V. [1 ]
Pirojkul, C. [1 ]
机构：
[1] Khon Kaen Univ, Fac Med, Srinagarind Hosp, Khon Kaen, Thailand
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [1] Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine
    Petekkaya, I.
    Gezgen, G.
    Roach, E. C.
    Solak, M.
    Altundag, K.
    Gullu, I.
    [J]. JOURNAL OF BUON, 2012, 17 (04): : 796 - 796
  • [2] Efficacy of capecitabine-based combination therapy and single-agent capecitabine maintenance therapy in patients with metastatic breast cancer
    Lv, Huimin
    Yan, Min
    Zhang, Mengwei
    Niu, Limin
    Zeng, Huiai
    Cui, Shude
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (06) : 692 - 697
  • [3] Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
    Pagliaro, Lance C.
    Perez, Cherie A.
    Tu, Shi-Ming
    Daliani, Danal D.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (06) : 487 - 491
  • [4] Salvage treatment with single-agent capecitabine (C) in patients (pts) with heavily pretreated advanced colorectal cancer (ACRC)
    Ioannidis, GN
    Ardavanis, AS
    Orphanos, GS
    Rigatos, GA
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 286 - 286
  • [5] A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma
    F. Mühr-Wilkenshoff
    W. Hinkelbein
    I. Ohnesorge
    K. J. Wolf
    E.-O. Riecken
    M. Zeitz
    H. Scherübl
    [J]. International Journal of Colorectal Disease, 2003, 18 : 330 - 334
  • [6] A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma
    Mühr-Wilkenshoff, F
    Hinkelbein, W
    Ohnesorge, I
    Wolf, KJ
    Riecken, EO
    Zeitz, M
    Scherübl, H
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2003, 18 (04) : 330 - 334
  • [7] Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer
    Huang, Hongyan
    Jiang, Zefei
    Wang, Tao
    Zhang, Shaohua
    Bian, Li
    Cao, Yang
    Wu, Shikai
    Song, Santai
    [J]. ANTI-CANCER DRUGS, 2012, 23 (07) : 718 - 723
  • [8] Systemic Therapy for Locally Advanced and Metastatic Cholangiocarcinoma
    Sookprasert, Aumkhae
    Chindaprasirt, Jarin
    Wirasorn, Kosin
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 : 3 - 6
  • [9] Single-agent vs combination therapy in advanced breast cancer: Potential roles of capecitabine
    Hudis, CA
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (10): : 13 - 16
  • [10] SINGLE-AGENT CAPECITABINE AS FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    [J]. JOURNAL OF IMAB, 2009, 15 (01): : 46 - 49
12345